Search results
3.6 million Medicare enrollees may now be eligible for Wegovy coverage
CNN via Yahoo News· 2 days agoAbout 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug Wegovy,...
Why has my Medicare prescription drug premium increased?
Las Vegas Review-Journal· 21 hours agoWhat is this all about? I am in excellent health and take no prescriptions. If I do not apply for a ...
Wave of Amicus Briefs Back Drug Price Plan at Trial Court Stage
Bloomberg Law· 2 hours agoThe Biden administration’s efforts to fend off legal challenges from the pharmaceutical industry battling Medicare drug price negotiations has drawn reinforcements ...
Millions of Medicare recipients could gain access to weight-loss drug
Newsweek· 2 days agoMillions of overweight or obese patients with heart conditions insured under Medicare could gain...
3 big changes coming to Medicare in 2025—and what they’ll mean for you
Fortune via Yahoo Finance· 3 days agoMedicare) or Medigap (Medicare Supplemental) or Part D prescription drug plans. CMS hopes to end...
Analysts revisit Humana stock price targets amid Medicare Advantage hit
TheStreet via Yahoo Finance· 12 hours agoUnder the act, private health plans approved by Medicare became known as Medicare Advantage Plans....
Alignment Health Plan Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 1 day agoAlignment Health Plan Medicare Advantage plans are available in six states and get average star...
... Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug,...
Sierra Sun Times· 21 hours agoIn a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of...
Why is Medicare Part D’s premium so high? | Chattanooga Times Free Press
Chattanooga Times Free Press· 6 days agoIf I do not apply for a Medicare prescription drug plan, do I still have to pay the extra $33.30?...
CENTENE CORPORATION REPORTS FIRST QUARTER 2024 RESULTS
WFRV 5 Green Bay· 1 hour ago2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023. Increases 2024 full year adjusted diluted EPS guidance by $0.10 to greater than $6.80. ST. LOUIS, April ...
